Matinas BioPharma Holdings Inc (FRA:6LJ0)
€ 2.69 0 (0%) Market Cap: 15.88 Mil Enterprise Value: 5.92 Mil PE Ratio: 0 PB Ratio: 0.92 GF Score: 52/100

Matinas BioPharma Holdings Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 13, 2022 / 07:00PM GMT
Release Date Price: €39.48 (-11.08%)
Chang Liu
Needham & Company, LLC - Analyst

Good afternoon, and welcome to the 21st Needham Healthcare Conference. My name is Chang Liu, and I will be the moderator for this presentation. We welcome Matinas BioPharma here today and its CEO, Jerry Jabbour. (Conference Instructions)

Without further ado, Jerry, would you like to start your presentation?

Jerry Jabbour
Matinas BioPharma Holdings, Inc. - CEO

Great. Chang, thanks so much. As Chang mentioned, I'm Jerry Jabbour, Co-Founder and CEO of Matinas, and we're thrilled to be here at the Needham 21st Annual Virtual Healthcare Conference. It's been a big week for our company, an exciting week for our company as we've had some validating news, which we think reflects not only the interest, but the data that's already been generated to date with our lipid nanocrystal or LNC delivery platform. And so I'm very grateful to have the opportunity today really for the first time publicly to address these latest developments, walk you through our overall business strategy and some of the exciting things we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot